 Comparison intravenous amrinone dobutamine congestive heart failure due cardiomyopathy prospective randomized study consecutive patients refractory congestive heart failure CHF due cardiomyopathy hemodynamic responses infusions amrinone dobutamine drugs pulmonary arterial wedge pressure right atrial pressure systemic vascular resistance cardiac index Amrinone decrease right atrial pressure dobutamine positive chronotropic effect dobutamine increase heart rate amrinone changes right atrial pulmonary arterial wedge pressures baroreceptor response preload Dobutamine increase stroke volume index amrinone percent patients amrinone dobutamine reduction equal pulmonary arterial wedge pressure Cardiac index equal similar numbers patients dobutamine Negative fluid balance patients amrinone patients dobutamine hemodynamic criteria patients micrograms/kg/min amrinone effective maintenance dose dobutamine variable important adverse effects drug regimen amrinone dobutamine effective safe agents short-term parenteral therapy patients dilated cardiomyopathy severe CHF unresponsive oral medication